DOJ has escalated its transgender care investigation by issuing grand jury subpoenas to hospitals, raising Fifth Amendment stakes and prompting some providers to halt services.
The Department of Justice has escalated its investigation into gender-affirming care for minors by issuing grand jury subpoenas to hospital systems, a significant tactical shift from the administrative subpoenas that federal courts had repeatedly refused to enforce [1]. The move raises the legal stakes substantially for providers, who now face the coercive weight of criminal process rather than civil regulatory demands. Several hospital systems have reportedly halted gender-affirming care services rather than absorb the compliance burden the subpoenas impose [1].
The escalation comes amid ongoing litigation in Rhode Island, where courts previously scrutinized and blocked DOJ administrative subpoena tactics targeting pediatric gender-care records [1]. A federal judge in that proceeding has sought to impose discipline on DOJ attorneys over their conduct in pursuing the earlier subpoenas, signaling judicial concern about the government's methods [1]. The underlying investigation targets the provision of gender-affirming medical treatment to minors, with the government seeking patient records from hospital systems that offered such care.
The switch to grand jury subpoenas carries distinct legal consequences. Recipients cannot simply refuse compliance without risking contempt of court, and the grand jury process imposes secrecy obligations that limit hospitals' ability to coordinate a public legal response or notify patients in real time [1]. The shift also forces providers to confront Fifth Amendment considerations, including whether compelled disclosure of patient records implicates constitutional protections in ways that administrative demands did not. For health systems, the calculus changes from regulatory resistance to potential criminal exposure for non-compliance, a distinction that reorders institutional risk assessments and alters how in-house counsel must advise leadership.
The practical effect is already visible in provider behavior. Hospitals pulling back from gender-affirming care in response to subpoena pressure, rather than as a result of any court order or legislative prohibition, illustrates how investigative tools can reshape medical practice before any charge is filed or any law is changed [1]. That dynamic is likely to draw further legal challenge, including potential motions to quash on Fourth and Fifth Amendment grounds and arguments invoking HIPAA's privacy protections for patient records.
What comes next will likely be determined in the Rhode Island proceedings and in any new challenges providers mount against the grand jury subpoenas. The disciplinary inquiry into DOJ attorney conduct adds a parallel track that could constrain the government's litigation posture. Defense counsel for affected hospitals are expected to press both procedural and constitutional objections in the weeks ahead [1].